Canada markets open in 29 minutes
  • S&P/TSX

    20,157.65
    +19.30 (+0.10%)
     
  • S&P 500

    4,255.15
    +7.71 (+0.18%)
     
  • DOW

    34,393.75
    -85.85 (-0.25%)
     
  • CAD/USD

    0.8207
    -0.0027 (-0.33%)
     
  • CRUDE OIL

    71.72
    +0.84 (+1.19%)
     
  • BTC-CAD

    49,242.97
    +759.27 (+1.57%)
     
  • CMC Crypto 200

    1,010.44
    +41.60 (+4.29%)
     
  • GOLD FUTURES

    1,868.10
    +2.20 (+0.12%)
     
  • RUSSELL 2000

    2,326.15
    -9.66 (-0.41%)
     
  • 10-Yr Bond

    1.5040
    +0.0030 (+0.20%)
     
  • NASDAQ futures

    14,125.00
    +0.25 (+0.00%)
     
  • VOLATILITY

    16.65
    +1.00 (+6.39%)
     
  • FTSE

    7,181.24
    +34.56 (+0.48%)
     
  • NIKKEI 225

    29,441.30
    +279.50 (+0.96%)
     
  • CAD/EUR

    0.6773
    -0.0020 (-0.29%)
     

Global Epigenetics Market (2020 to 2028) - Size, Share & Analysis Report - ResearchAndMarkets.com

·4 min read

The "Epigenetics Market Size, Share & Analysis By Product, By Technology, By Application, By End-Use, And By Region, Forecast To 2028" report has been added to ResearchAndMarkets.com's offering.

Prevalence of various types of cancer, coupled with rising need for advanced cancer treatment and drugs are key factors driving market revenue growth.

Market Size - USD 9,143.1 Million in 2020, Market Growth - CAGR of 18.8%, Market Trends - Increasing research and development to explore novel treatment for cancer.

The global epigenetic market size is expected to reach USD 36.52 Billion in 2028, and register a CAGR of 18.8% during the forecast period. Rising number of deaths by cancer, global geriatric population globally, and rising awareness regarding need for epigenetic are factors expected to drive market growth. According to a report by World Health Organization, number of cancer patients is going to increase to 19.3 Million by 2025 globally.

High cost of instruments required for epigenetics research and maintenance are factors that could hamper market growth to some extent.

Companies Mentioned

  • Illumina (U.S.)

  • Thermo Fisher Scientific (U.S.)

  • Merck Millipore (U.S.)

  • Abcam (U.K.)

  • Active Motif (U.S.)

  • Bio-Rad Laboratories (U.S.)

  • New England Biolabs (U.S.)

  • Agilent (U.S.)

  • QIAGEN (Netherlands)

  • Zymo Research (U.S.)

  • PerkinElmer (U.S.)

  • Diagenode (Belgium).

Reasons to Buy the Report

  • A robust analysis and estimation of the Epigenetics Market with four levels of quality check - in-house database, expert interviews, governmental regulation, and a forecast specifically done through time series analysis

  • A holistic competitive landscape of all the major players in the Epigenetics Market. The report covers their market shares, strategic initiatives, new product launches, R&D expenditure, M&As, Joint ventures, expansionary plans, product wise metric space analysis and key developments

  • Go-to-market strategies specifically formulated in line with location analysis which takes into the factors such as government regulations, supplier mapping, supply chain obstacles, and feedback from local vendors

  • Most deep dive segmental bifurcation available currently in the market. Our stellar methodology helps us understand the overall gamut of the supply chain and will help you explain the current market dynamics

  • Special focus given on vendor landscape, supplier portfolio, customer mapping, production capacity, and yearly capacity utilization

Key Topics Covered:

Chapter 1. Market Synopsis

Chapter 2. Executive Summary

Chapter 3. Indicative Metrics

3.1. Increasing geriatric population

3.2. Rising prevalence of cancer

3.3. Reducing sequencing time

Chapter 4. Epigenetics Segmentation & Impact Analysis

4.1. Epigenetics Segmentation Analysis

4.2. Epigenetics Market Value Chain Analysis, 2018 - 2028

4.3. Regulatory framework

4.4. Epigenetics Market Impact Analysis

4.4.1. Market driver analysis

4.4.1.1. Increasing research activities in epigenetics

4.4.1.2. Need for personalized health care

4.4.2. Market restraint analysis

4.4.2.1. High initial and maintenance cost

4.4.2.2. Concerns regarding quality of antibodies

4.5. Key opportunities prioritized

4.6. Epigenetics Pricing Analysis

4.7. Industry analysis - Porter's

4.8. Epigenetics PESTEL Analysis

Chapter 5. Epigenetics Market By Product Type Insights & Trends

5.1. Epigenetics Product Type dynamics & Market Share, 2021 & 2028

5.2. Reagents

5.3. Kits

5.4. Instruments

5.5. Enzymes

5.6. Services

Chapter 6. Epigenetics Market By Technology Insights & Trends

6.1. Epigenetics Technology dynamics & Market Share, 2021 & 2028

6.2. DNA Methylation

6.3. Histone Methylation

6.4. Histone Acetylation

6.5. Large non-coding RNA

6.6. Micro-RNA modifications

6.7. Chromatin Structures

Chapter 7. Epigenetics Market By Application Insights & Trends

7.1. Epigenetics Application dynamics & Market Share, 2021 & 2028

7.2. Oncology

7.3. Non-oncology

Chapter 8. Epigenetics Market By End-Use Insights & Trends

8.1. Epigenetics End-Use dynamics & Market Share, 2021 & 2028

8.2. Academic and Research institutes

8.3. Pharmaceutical and Biotechnology Companies

8.4. Contract Research Organizations

Chapter 9. Epigenetics Market Regional Outlook

9.1. Epigenetics Market share by region, 2021 & 2028

9.2. North America

9.3. Europe

9.4. Asia Pacific

9.5. Middle East & Africa

9.6. Latin America

Chapter 10. Competitive Landscape

10.1. Market Revenue Share by Manufacturers

10.2. Manufacturing Cost Breakdown Analysis

10.3. Mergers & Acquisitions

10.4. Strategy Benchmarking

10.5. Vendor Landscape

Chapter 11. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/6w8sq4

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005853/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900